Piper Sandler & Co’s BioTelemetry, Inc. BEAT Stock Holding History

Piper Sandler & Co’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-35,000	Closed	-$428K	–	118
2015 Q3	$428K	Sell	35,000 -35,000	-50%	-$446K	0.46%	24
2015 Q2	$660K	Buy	+70,000	New	+$648K	0.4%	24
2014 Q4	–	Sell	-50,000	Closed	-$336K	–	198
2014 Q3	$336K	Buy	+50,000	New	+$351K	0.17%	51
2014 Q2	–	Sell	-35,000	Closed	-$353K	–	176
2014 Q1	$353K	Buy	+35,000	New	+$322K	0.31%	39

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piper Sandler & Co's BEAT Position: Q4 2015 in Review

Piper Sandler & Co sold out of BioTelemetry, Inc. (BEAT) in Q4 2015, closing a stake of 35,000 shares — an estimated $428K sold.

Piper Sandler & Co first reported a position in BEAT in Q1 2014 and held it in 4 quarters. The position peaked at $660K in Q2 2015. 115 funds tracked by Wall St. Rank hold BEAT as of Q4 2015.

Piper Sandler & Co reported no remaining BioTelemetry, Inc. position as of Q4 2015 after selling out during the quarter.
Piper Sandler & Co sold 35,000 BioTelemetry, Inc. shares in Q4 2015, an estimated $428K.
Piper Sandler & Co first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 4 quarters.
Piper Sandler & Co's BioTelemetry, Inc. position peaked at $660K in Q2 2015.
115 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.